Ferhat Farsi PhD

Dr. Ferhat Farsi, CEO and founding partner of CinnaGen İlac, shares the company’s plans to become Turkey’s leading biotech entity and gives insights into the group’s international expansion plans. He highlights the potential of biotechnology and rare disease therapies in the Turkish market, while also acknowledging the obstacles to their development.